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Bath Breakfast Project (BBP) - Examining the role 
of extended daily fasting in human energy 
balance and associated health outcomes: 
Study protocol for a randomised controlled 
trial [ISRCTN31521726] 
James A Betts1, Dylan Thompson1, Judith D Richardson1, Enhad A Chowdhury1, Matthew Jeans1, 
Geoffrey D Holman2 and Kostas Tsintzas3* 
Abstract 
Background: Current guidance regarding the role of daily breakfast in human health is largely grounded in cross-
sectional observations. However, the causal nature of these relationships has not been fully explored and what 
limited information is emerging from controlled laboratory-based experiments appears inconsistent with much 
existing data. Further progress in our understanding therefore requires a direct examination of how daily breakfast 
impacts human health under free-living conditions. 
Methods/Design: The Bath Breakfast Project (BBP) is a randomised controlled trial comparing the effects of daily 
breakfast consumption relative to extended fasting on energy balance and human health. Approximately 70 men 
and women will undergo extensive laboratory-based assessments of their acute metabolic responses under fasted 
and post-prandial conditions, to include: resting metabolic rate, substrate oxidation, dietary-induced thermogenesis 
and systemic concentrations of key metabolites/hormones. Physiological and psychological indices of appetite will 
also be monitored both over the first few hours of the day (i.e. whether fed or fasted) and also following a 
standardised test lunch used to assess voluntary energy intake under controlled conditions. Baseline measurements 
of participants’ anthropometric characteristics (e.g. DEXA) will be recorded prior to intervention, along with an oral 
glucose tolerance test and acquisition of adipose tissue samples to determine expression of key genes and 
estimates of tissue-specific insulin action. Participants will then be randomly assigned either to a group prescribed 
an energy intake of ≥3000 kJ before 1100 each day or a group to extend their overnight fast by abstaining from 
ingestion of energy-providing nutrients until 1200 each day, with all laboratory-based measurements followed-up 6 
weeks later. Free-living assessments of energy intake (via direct weighed food diaries) and energy expenditure (via 
combined heart-rate/accelerometry) will be made during the first and last week of intervention, with continuous 
glucose monitors worn both to document chronic glycaemic responses to the intervention and to verify 
compliance. 
Trial registration: Current Controlled Trials ISRCTN31521726. 
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Background 
It is over four decades since Pavel Fábry and colleagues 
published their studies showing positive correlations 
between infrequent daily meal patterns and overweight, 
hypercholesterolaemia, impaired glucose tolerance and 
ischaemic heart disease [1]. Since then, it is certainly 
notable that the  increased prevalence of overweight and  
obesity in Western Societies has been paralleled by a pro­
gressive decline in breakfast consumption [2]. However, 
subsequent scientific literature has not substantially pro­
gressed understanding beyond the initial cross-sectional 
associations published in the late 1960s. While subse­
quent cross-sectional and/or longitudinal investigations 
have undoubtedly clarified certain aspects of these corre­
lations and confirmed such relationships across a wider 
population range, it is impossible to establish any degree 
of causality from these data due to major confounding 
variables; for example, the fact that frequent breakfast 
consumers also tend to exhibit numerous other healthful 
lifestyle choices such as lower fat/alcohol intakes, higher 
fibre/micronutrient intakes, not smoking and also a ten­
dency to exercise more [3-11]. 
In terms of existing cross-sectional evidence linking 
increased adiposity with infrequent or insufficient break­
fast consumption, the wealth of available literature does 
conform to the stated positive relationship [1,7,11-21]]. 
However, the majority of these large-scale epidemiologi­
cal studies have involved self-reported dietary records, 
which are known to underestimate absolute energy 
intake to a greater extent for more overweight individuals 
[22]. Indeed, Summerbell et al. (1995) reanalysed the data 
from 3 existing studies across a range of age groups and 
found that the commonly reported associations between 
frequent daily meal patterns/high energy intake at break­
fast and overweight do not persist once corrected for 
‘unreasonably low’ energy intakes [23]. These corrected 
results therefore fall into agreement with the one other 
existing cross-sectional study which found no relation­
ship between daily meal frequency and percent body fat­
ness as determined by hydrostatic weighing, in which 
dietary records were managed on an individual basis via 
telephone [24]. Notwithstanding such methodological 
issues, it might be suggested that one benefit of a fre­
quent meal pattern would be a lasting satiating effect, 
possibly related to the high fibre content of many break­
fast foods [25]. Indeed, at least three intervention studies 
are consistent with this reasoning [26-28], although many 
cross-sectional studies have not observed any difference 
in overall energy intake between frequent and infrequent 
breakfast consumers [12,13,17,29] or have even found 
higher energy intakes associated with breakfast consump­
tion [13,15,16,20]. These latter studies necessarily impli­
cate some interaction between energy intake and energy 
expenditure (i.e. if breakfast consumers are leaner), 
although the only evidence for such an effect comes from 
the study by Wyatt et al. (2002), in which self-reported 
physical activity was higher amongst individuals who 
reported having breakfast on more than 3 days each 
week [29]. Ultimately, the balance of currently available 
cross-sectional evidence cannot provide information 
regarding the direction or even the existence of any cau­
sal relationship between breakfast consumption and 
weight change. Moreover, issues regarding the accurate 
measurement of changes in energy intake may even ques­
tion the validity of these findings. 
To gain greater insight into this field, it is necessary to 
move towards higher levels of evidence beyond simple 
cross-sectional observations. Fortunately, five of the stu­
dies that have documented baseline correlations between 
weight status and breakfast frequency have also con­
ducted longitudinal examinations of breakfast habits and 
weight change over between 3 and 13 years in both chil­
dren [11,18,20] and adults [19,21]. In contrast to the 
cross-sectional evidence detailed above, a far less consis­
tent pattern of findings is apparent. Barton et al. (2005), 
Timlin et al. (2008) and Bazzano et al. (2005) have all 
reported a reduced prospective risk of weight gain with 
frequent breakfast consumption over 5-10 years follow-
up in children [18], adolescents [11] and adults [19], 
respectively; while Kant and colleagues found no rela­
tionship whatsoever between weight change over 8-10 
years and daily meal pattern either at baseline or at fol­
low-up, although an infrequent daily meal pattern does 
not necessarily indicate that breakfast was omitted [21]. 
Interestingly, in that study the authors also note that 
daily meal pattern was unrelated to self-reported physical 
activity either at baseline or at follow-up, although no 
actual data are reported. The balance of longitudinal evi­
dence in this area becomes yet more equivocal when con­
sidering the study by Berkey et al. (2003), in which a 
large cohort of children between the ages of 9 and 14 
were monitored annually over three years [20]. Impor­
tantly, this study also stratified participants according to 
weight and actually found omission of breakfast to be 
positively associated with prospective weight loss in over­
weight children. In contrast, normal weight children in 
this study displayed a trend in the opposite direction in 
that more weight was gained over time when breakfast 
was always omitted rather than consumed. It is also note­
worthy that recent longitudinal evidence has reported 
detrimental cardiovascular and metabolic health out­
comes in association with breakfast skipping even when 
adjusted for physical activity status and increased body 
fatness [i.e. waist circumference; [30]]. Overall, the longi­
tudinal studies summarised here question the causal nat­
ure of cross-sectional associations between breakfast and 
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adiposity but also introduce the interesting possibility 
that the strength and direction of this relationship may 
be mediated by current weight status. 
Evidence from randomised controlled trials in this 
area comes from a wide range of innovative research 
designs with varied research questions. Specifically, 
many of these studies have focused on either consuming 
a low energy breakfast or reducing the number of meals 
consumed on a daily basis, as opposed to the complete 
omission of breakfast per se [27,31,31-44]. In terms of 
the former, low energy breakfasts have been found to 
increase subsequent energy intake during a test meal 4 
hours later [34] but not sufficiently to compensate for 
the reduced energy intake at breakfast [36,45]. In fact, 
even if overall energy intake is unaffected, it seems that 
reducing energy intake at breakfast for 6 weeks may 
actually result in greater reductions in body fat mass but 
lower overall weight loss due to the preservation of lean 
tissue mass [35]. Conversely, those studies which have 
varied the number of meals consumed on a daily basis 
from between 1 and 9 meals per day have found no 
effect on energy intake, resting energy expenditure or 
change in body mass [27,31-33,46-48], although one 
recent study has reported an increase in fat mass with 
omission of an afternoon meal for 28 days [47] and 
another has detected higher overall energy intake from 
meals of prescribed content during a 14 day period of 
breakfast omission [26]. The effects of varied meal fre­
quency on dietary-induced thermogenesis (DIT) are 
even less consistent, with reports of DIT being either 
unaffected [27,40,41], increased [37,38] or in fact 
decreased [32,39] by an infrequent daily feeding pattern. 
In terms of selected health outcomes typically associated 
with chronic weight change, causal evidence is also 
inconsistent with what might be expected based upon 
cross-sectional observations. For example, there is some 
tentative evidence that a regular daily meal frequency 
(6-9 meals per day) for 2 weeks can improve insulin 
sensitivity and blood lipid profiles relative to more chao­
tic and/or less frequent feeding patterns [43,44]. It is 
therefore intriguing that intermittent 24 hour fasting 
every other day for 2 weeks also has the capacity to 
improve insulin sensitivity, even without any significant 
short-term reduction in body mass [49]. However, such 
alternate-day fasting also reduces resting metabolic rate, 
so may favour weight gain and associated consequences 
in the long-term [50]. 
Nonetheless, as mentioned previously, neither varied 
meal frequency nor reduced energy intake at breakfast 
necessarily precludes the ingestion of food in the morn­
ing to interrupt an overnight fast. It is therefore very 
interesting that so few randomised controlled trials have 
directly contrasted the impact of omitting breakfast (i.e. 
extending the daily overnight fast) from an otherwise 
matched diet in terms of components of energy balance 
and subsequent weight loss [26,46,51]. One of these stu­
dies has already been discussed in relation to the 
observed increase in energy intake when breakfast was 
omitted from the habitual diet [26] but also reported 
evidence of impaired glycaemic control and elevated 
blood lipids with breakfast omission, despite the fact 
that body mass was unaffected. These findings are con­
sistent with the more recent work of Stote et al. (2007)  
in relation to changes in body mass over 8 weeks of 
extended morning fasting [46], along with metabolic 
data taken from the same study [52]. The third trial spe­
cific to inclusion/omission of breakfast from the habitual 
diet also involved prescribed dietary intake but with 
restricted energy intake (i.e. ~ 5000 kJ·d-1) over a period 
of 12 weeks, provided either as 3 meals each day 
(including a cereal breakfast) or with 2 meals each day 
(including an additional bran muffin with each meal to 
maintain energy/fibre intake) [51]. 
Importantly, the authors of this latter study also strati­
fied participants according to their usual breakfast eating 
habits at baseline and found habitual breakfast consu­
mers lost more weight by omitting breakfast while habi­
tual breakfast non-consumers lost more weight by 
introducing breakfast. This study therefore indicates that 
the success of a weight loss programme can be mediated 
to an extent by the degree to which that programme dif­
fers from each individual’s usual dietary habits but also 
revealed that not consuming breakfast increases the 
probability of impulsive snacking throughout the day, 
which is known to be associated with a poorer overall 
dietary profile [53]. It should be noted, however, that all 
three of the  studies cited  above have involved some  
degree of prescription or restriction in terms of dietary 
intake, so may not therefore be sensitive to potential 
‘real-world’ alterations in eating behaviour and, further­
more, only the study by Stote et al. (2007) has attempted 
to quantify any effect of interventions on free-living 
energy expenditure. In that study, accelerometers (Acti­
graph™) were used to monitor weekly physical activity 
counts and it was reported that there was no evidence of 
any difference in physical activity between treatments 
[46]. However, this measurement tool has been shown to 
lack reliability when applied to free-living conditions [54] 
and may not therefore have been sufficiently sensitive to 
detect subtle alterations in spontaneous low-to-moderate 
intensity physical activity [55], which intuitively could be 
considered as the most responsive element of physical 
activity to modified eating patterns. 
What becomes most clear when reviewing the above lit­
erature is that very few existing studies have actually 
attempted to quantify the impact of breakfast on the most 
malleable component of energy expenditure, namely phy­
sical activity energy expenditure [27,29,31,38,42,46]. Even 
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amongst these six studies, it is notable that one simply 
reported cross-sectional associations based upon a self-
administered physical activity questionnaire [29], while 
four others were randomised controlled trials that directly 
assessed energy expenditure using a whole-body calori­
meter [although this method understandably restricts par­
ticipants’ spontaneous free-living physical activity; 
[27,31,38,42]]. Therefore, aside from the aforementioned 
study by Stote et al. in which overall physical activity level 
was estimated using accelerometers [46], only Verboeket­
van de Venne et al. (1993) have provided data regarding 
changes in daily physical activities with varied feeding fre­
quency (i.e. 2 versus 7 meals·d-1). Physical activity levels in 
that study were determined as the difference between rest­
ing energy expenditure measured using the whole-body 
calorimeter and average daily free-living energy expendi­
ture measured using the doubly-labelled water technique, 
which revealed no effect of feeding frequency [38]. 
A central aim of this project is therefore to conduct a 
trial in accordance with current CONSORT guidelines 
which will employ contemporary measurement tools (i.e. 
combined heart rate and accelerometry) to generate objec­
tive and reliable data regarding physical activity energy 
expenditure under free-living conditions in response to 
varied daily meal frequency (i.e. daily breakfast versus 
extended fasting). In contrast to doubly-labelled water, 
this approach is not limited only to monitoring total 
energy expenditure but also permits specific evaluation of 
physical activity profiles in terms of the precise intensity 
and duration of various daily activities. This novel aspect 
of the work is complemented by both laboratory- and 
field-based assessments of all other components of energy 
balance, along with integration of various other techniques 
not previously combined in relation to this dietary inter­
vention. In particular, changes in body composition will be 
accurately monitored via repeated DEXA scanning, con­
tinuous glucose monitors will provide a highly sensitive 
and meaningful analysis of glycaemic control with modi­
fied feeding patterns and, lastly, detailed blood/adipose tis­
sue analyses will provide the most mechanistic 
information to date on this topic, thus establishing the 
existence and direction of any causal relationships between 
variables. In summary, there is some support for a positive 
relationship between extended daily fasting and energy 
balance, which can lead to a range of inter-related negative 
health consequences, and this project aims to address the 
casual nature of these associations via the following 
objectives: 
i.) To examine the impact of a single extended fast 
on the acute metabolic and behavioural mechanisms 
of short-term energy balance regulation. 
ii.) To determine whether habitual extended fasting 
is causally related to chronic positive energy balance 
and establish the mechanisms through which this 
relationship may operate. 
iii.) To translate the effects of habitual extended 
fasting into selected health outcomes related to 
chronic positive energy balance (i.e. adiposity, insulin 
resistance and cardiovascular disease). 
Methods/Design 
Approach to the Research Question 
As illustrated in Figure 1, extended daily fasting has the 
potential to impact upon adiposity, insulin resistance and 
cardiovascular disease via the acute influences of a single 
extended daily fast on a given day in terms of contribut­
ing to a more positive daily energy balance (Objective i) 
but also via the chronic metabolic and/or behavioural 
adaptations which may occur with habitual exposure to 
extended daily fasting over a more prolonged period 
(Objective ii). This project will take advantage of recent 
technological advances to comprehensively assess all 
aspects of energy balance and the physiological mechan­
isms which may underpin causal relationships between 
feeding frequency and energy balance (i.e. energy balance 
hormones). Furthermore, this approach of applying state-
of-the-art analytical techniques to further progress cur­
rent understanding will also provide valuable insight by 
examining selected health-related outcomes at a variety 
of levels ranging from molecular to whole-body (Objec­
tive iii). Specifically, many components and conse­
quences of positive energy balance (e.g. poor dietary 
composition, sedentary behaviour and adiposity) have 
been well established as independent risk factors for 
insulin resistance and associated cardiovascular disease 
[56-58], with chronic low-grade inflammation strongly 
implicated in the latter [59]. In particular, systemic con­
centrations of C-reactive protein (CRP) have been shown 
to exhibit positive correlations with fasted glucose con­
centrations [60], atherosclerotic progression [61] and the 
incidence of initial coronary heart disease events [62]. It 
is therefore anticipated that the range of measures 
described below will address the stated objectives both 
from a basic and an applied science perspective to estab­
lish causal mechanisms and relationships to clinical out­
comes, thus providing detailed yet practically valuable 
understanding in relation to public health policy and 
clinical practice. 
Trial Design 
Objective i will be addressed by way of an acute rando­
mised cross-over comparison while Objective ii and 
Objective iii will be addressed via a chronic independent 
comparison of two parallel and randomly assigned 
groups, both involving a contrast between daily breakfast 
consumption and extended fasting. Figure 2 illustrates 
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Figure 1 Proposed mechanistic pathway underlying the relationships between extended daily fasting, energy balance and health 
outcomes. 
the course of progress through this trial consistent with 
current CONSORT guidelines for reporting randomised 
trials [63]. 
Participants/Eligibility 
A total cohort of 60-70 men and women will take part 
in the main part of the experiment, half of whom will 
be broadly classified as normal weight (BMI ~20-25 
kg·m-2), whereas the other half will be obese (BMI ≥30 
kg·m-2). This broad classification according to BMI is 
intended to generate two separate and diverse overall 
populations for subsequent more accurate and gender 
specific stratification based upon DEXA-derived fat-
mass index (♂ FMI ≤7.5 kg·m-2<; ♀ FMI ≤11 kg·m-2<), 
Figure 2 Flow diagram illustrating progress through each phase of the trial [adapted from current CONSORT guidelines; [63]]. 
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thus controlling for differences in lean tissue [64] to 
allow separate analyses according to whether a given 
individual is ordinarily able to attain long-term energy 
balance. Furthermore, baseline breakfast habits will be 
included as a co-variate in our analysis to consider the 
distinct responses of frequent versus infrequent breakfast 
consumers, with frequent breakfast consumption defined 
as the ingestion of ≥209 kJ within two hours of waking 
on most days of the week. Both the above factors will 
be included in a stratified randomisation scheme, with 
generation of 4 separate block randomisation schedules 
to ensure an equal distribution of normal/overweight 
and in/frequent breakfast consumers between treatment 
groups. These randomisation schedules will be produced 
by the principal investigator (JB) using a computer-
based random number generator, with full details of the 
overall randomisation scheme only to be published in 
full once group allocation is complete to complicate 
deciphering of the allocation sequence by those involved 
in trial enrolment [65]. Further procedures to conceal 
the allocation sequence are that the two individuals 
responsible for trial enrolment (JR & EC) will indepen­
dently request group assignments from the principal 
investigator via email immediately upon verification of 
eligibility according to pre-stated inclusion criteria. 
Combining these separate requests into the same set of 
randomisation schedules in order of receipt therefore 
renders it impossible for either individual to confidently 
predict upcoming group assignments without prior 
knowledge of the other’s requests. Moreover, even with 
this knowledge, randomisation at the point of objectively 
establishing eligibility ensures that the sequence in 
which requests are received is determined before ade­
quate information becomes available to predict the likely 
responsiveness of any given individual to each 
treatment. 
Lastly, any volunteer fulfilling all eligibility criteria 
(thus equivalent to the main study population) but 
unable to commit to the main study for other reasons 
(e.g. impossible to schedule trials in the required time-
frame, unwilling to provide tissue samples, etc.) will be 
invited to participate as part of a ‘true’ control group. 
This group will complete only the free-living element of 
the study (Phase II; see later) while simply maintaining 
their usual lifestyle, therefore providing some back­
ground context regarding the extent to which the free-
living measures themselves (i.e. dietary & physical activ­
ity monitoring) may impact outcomes but without 
necessitating any extended visits to the laboratory for 
tissue samples. These volunteers for the proposed work 
will be recruited from the local community (South West 
UK) via public advertisement (e.g. local press/radio) and 
will not be provided any financial incentive for partici­
pation. The protocol described herein was reviewed and 
approved by the National Health Service South West 3 
Research Ethics Committee (10/H0106/13). 
Inclusion Criteria 
• Aged 21-60 
• Body Mass Index 20-25 kg·m-2 or >30 kg·m-2 
• Able and willing to safely comply with all study 
procedures 
• Able to provide written informed consent for 
participation 
• Females must maintain a record of regular men­
strual cycle phase or contraceptive use 
• No anticipated changes in diet and/or physical 
activity habits during the study period (e.g. pre-
planned holidays, diets/exercise plan, etc.) 
Exclusion Criteria 
• Any reported condition or behaviour deemed 
either to pose undue personal risk to the participant 
or introduce bias into the experiment 
• Any reported use of substances which may pose 
undue personal risk to the participants or introduce 
bias into the experiment 
• Any individual whose habitual lifestyle does not 
conform to a standard sleep-wake cycle (e.g. shift 
workers) 
• Simultaneous or recent (i.e. last 3 months) partici­
pation in another clinical trial or blood donation, to 
allow full recovery of blood volume [66] 
• Any reported recent (i.e. last 6 months) shift (>1 
kg) in body mass 
• Any reported tendency towards keloid scarring 
• Any reported bleeding disorder 
• Females known to be pregnant or planning to 
become so over the course of the study 
• Females with oral or implanted contraceptives 
fitted within 6 months of participation [67] 
• Females who are breastfeeding 
Statistical Approach/Power Estimation 
The number of research participants to be recruited was 
estimated based upon a worthwhile effect dictated by 
the smallest shift in energy balance necessary to induce 
chronic weight loss. Specifically, one of the most similar 
studies to the proposed work applied doubly-labelled 
water to measure average daily energy expenditure in a 
population not dissimilar to that planned [38], from 
which a mean of ~12000 kJ·d-1 might be expected with  
a standard deviation in the region of ~2000 kJ·d-1. The  
daily breakfast to be consumed in this trial will provide 
in excess of ~3000 kJ·d-1 and our  pilot work using  this  
breakfast indicates that this is likely to stimulate meta­
bolism in the lead up to lunch by ~150 kJ·d-1 and 
reduce energy intake at lunch by ~150 kJ·d-1, relative to 
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continued fasting. Therefore, for breakfast consumption 
to exert a worthwhile effect on net energy balance (i.e. 
sufficient to compensate for the energy it provides 
directly), physical activity energy expenditure would 
need to increase and/or subsequent energy intake to 
decrease by a further 2700 kJ·d-1. Using  the above  fig­
ures, a worthwhile increase in energy expenditure would 
require ~14 participants in each treatment group to 
confer a 90% probability of detecting such an effect sta­
tistically using a two-tailed t-test with an alpha level of 
0.05. A total of 70 participants will therefore be 
recruited for the main study treatment arms in view of 
the 14% drop-out rate reported by Schlundt et al. 
(1992) when placing similar demands on volunteers 
[51], thus aiming to achieve at least 60 participants to 
provide sufficient statistical power even when the overall 
breakfast versus no breakfast groups are stratified 
according to FMI (with baseline breakfast habits, gender 
and age included as co-variates in the analysis). None­
theless, to minimise the negative impact of loss to fol­
low-up on validity, participants will be advised at trial 
enrolment to very carefully consider the required invest­
ment of time and effort relative to their current and 
forthcoming commitments outside of the trial, such that 
exclusions based on likely withdrawal can be made prior 
to randomisation [68]. Any unforeseen circumstances or 
withdrawal of consent subsequently resulting in loss to 
follow-up will be documented fully in the final trial 
report. Data collected from these individuals to the 
point of loss will then be compared with those who 
complete each treatment to determine whether the over­
all conclusions of the trial may be generalised beyond 
populations reflective of the latter (i.e. to anyone willing 
to be randomised). 
As with the primary outcome measure, secondary 
variables will also be analysed using either paired or 
independent t-tests applied to simple summary statistics 
between groups or trials, respectively (e.g. fasted/peak 
values, incremental area under curve, average value over 
24 h, etc.). Given that these sample size estimations are 
based on a primary outcome that inherently displays a 
relatively large inter-individual variability, it is antici­
pated that the more consistent responses of secondary 
variables will also be detectable with the selected sample 
size. 
Experimental Protocol 
Objective i - The first  phase of the proposed  work  
(Phase I) will involve two laboratory-based examinations 
of the acute metabolic and behavioural responses to 
extended fasting relative to ingestion of a standardised 
breakfast. These trials will be applied in a randomised 
and counterbalanced order with 3-28 days interval 
except for eumenorrheic women, whose trials will be 
separated by 28 ± 2 days and only at least 3 and at most 
10 days after the onset of menses (i.e. follicular phase) 
to ensure that the effects of menstrual cycle on the 
majority of hormones and therefore resting metabolic 
rate (RMR) and appetite will be both minimal and stan­
dardised between trials [69-71]. These acute trials will 
be conducted in our resting metabolism laboratory in 
accordance with current guidelines for best practice in 
measuring resting metabolic rate [72]. Most notably, 
ambient temperature in this laboratory is maintained 
between 20 and 25°C (with intra-individual trials stan­
dardised within 2°C) and participants will arrive for test­
ing  at 8  am  (±1 h) in a 10  hour  fasted  state but  having  
ingested 1 pint of plain water upon waking following 
standardised physical activity and diet (the latter to 
incorporate either daily breakfast or extended fasting 
according to the group randomisation described later, 
thus permitting meaningful comparisons with follow-up 
visits). Repeated 5 minute resting expired gas samples 
will be collected over 30 minutes (after 20 minutes of 
quiet rest) to establish RMR and substrate selection 
before a cannula will be fitted to an antecubital vein for 
the acquisition of a baseline 15 ml blood sample, along 
with further samples throughout that day. 
At this stage, participants will provide ratings of hun­
ger and appetite using validated visual analogue scales 
[73], for subsequent follow-up post-breakfast and also 
pre-post lunch and at the end of day. They will then 
receive either no breakfast or a typical standardised 
breakfast (composed of cereal, toast and orange juice) 
with the opposite treatment applied in each participant’s 
second trial). The specific food and macronutrient com­
position of this breakfast has been described previously 
[74] and provides quantities intended to deliver 14 mg 
carbohydrate per kJ of each individual’s previously  
established RMR. Fifteen minutes later or upon comple­
tion of the breakfast (if longer than 15 minutes is 
required) a 3 hour post-prandial period will commence, 
involving collection of all urine output (for determina­
tion of urea nitrogen excretion) with hourly expired 5 
minute gas samples to assess changes in substrate meta­
bolism (i.e. carbohydrate, lipid and protein oxidation) 
and DIT (i.e. post-prandial energy expenditure minus 
RMR). Fifteen millilitre blood samples (including 5 ml 
waste) will also be drawn 15, 30 & 60 minutes post-
breakfast, then at hourly intervals to determine systemic 
concentrations of: glucose; lactate; insulin; NEFA; urea; 
‘energy balance hormones’ that are known to play a cen­
tral role in the regulation of metabolic rate, appetite and 
spontaneous physical activity (e.g. free thyroxine, adipo­
nectin, CCK, total/acylated ghrelin, leptin & PYY); and 
also cytokine concentrations (e.g. interleukin-6 and 
TNF-a), in view of recently documented differences in 
post-prandial inflammatory responses to varied meals 
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across different populations [75] (with low/high density 
lipoprotein cholesterol and CRP only followed-up at the 
3 hour time-point). Participants will then be provided 
with a test meal of standardised composition (1 kg 
cooked Sainsbury’s™ penne pasta and Ragu™ tradi­
tional tomato sauce; prepared at a ratio of 1:1 uncooked 
mass) along with ad libitum plain water (although parti­
cipants will ingest the same volume of water as in their 
first trial during all subsequent visits), which we have 
previously employed during pilot work to estimate likely 
differences in voluntary energy intake. At this stage, par­
ticipants will be left alone in the laboratory and receive 
a recorded message stating: “We ask that you continue 
eating until you have satisfied your hunger. The lunch 
will remain in front of your for at least 30 minutes, at 
which point the post-lunch timer will be started, 
although you will be allowed to continue eating if you 
are still hungry.” 
The bowl of pasta will be refilled every 10 minutes to 
minimise any visual feedback in the regulation of appe­
tite. To gain additional insight regarding psychological 
reward and food hedonics, a validated labelled magni­
tude scale [76] will be administered following the first 
and last mouthful of this meal to reliably assess the 
degree of ‘pleasantness’ associated with ingestive beha­
viour. The 3 hour post-prandial period will then be 
repeated exactly as following breakfast (but without the 
15-30 minute samples) to track metabolic responses to 
lunch. 
Objective ii - Phase II of testing will commence 
within 3-28 days after completion of each participants’ 
second trial under Phase I of testing (thus using partici­
pants’ breakfast trial along with the measures described 
above as a baseline). This trial schedule will again be 
used for all participants other than for eumenorrheic 
women, who will follow the same restrictions as 
described above and therefore occasionally be required 
to complete their first trial under Phase II prior to the 
completing the second trial under Phase I. In such 
cases, these participants’ 6-week intervention will simply 
be deferred for two weeks (i.e. enabling completion of 
Phase I) to allow follow-up measures to be taken at the 
same stage in the menstrual cycle. The first visit under 
Phase II will begin with participants again arriving in 
the laboratory at 8 am (±1 h) having adhered to the 
same standardisation procedures as described for Phase 
I. Measurements of body mass and adiposity based on 
hip and waist circumference (i.e. widest gluteal girth & 
mid-point between lowest rib and iliac crest, respec­
tively), sagittal abdominal height (using a Holtain-Kahn 
calliper at the iliac crest) and body composition via 
DEXA (Hologic Discovery W) will also be made at this 
visit, before a small (~1 g) sample of subcutaneous adi­
pose tissue will be acquired using a 14 G needle to 
determine basal expression of key genes related to appe­
tite and physical activity regulation (e.g. adiponectin and 
leptin) and energy expenditure (e.g. UCPs). 
This second phase of data collection will involve each 
participant being randomly assigned either to an 
extended daily fasting group (only plain water permitted 
until 1200 each day) or a breakfast consumption group 
(prescribed intake of ≥3000 kJ before 1100 each day, to 
include at least 1500 kJ within two hours of waking) for 
a period of 6 weeks [a duration previously shown to be 
sufficient for dietary modification to induce detectable 
changes in energy balance and body composition; [35]. 
To facilitate this process, participants assigned to the 
breakfast group will be provided with detailed examples 
of appropriately energetic breakfasts and the energy 
content of other typical breakfast foods, although the 
breakfasts consumed will ultimately be self-selected by 
each individual on a daily basis. Upon completion of 
this 6 week dietary modification, participants will return 
to the laboratory for follow-up of all anthropometric 
measures and a second subcutaneous adipose tissue 
biopsy to determine whether the intervention has 
altered the expression of those genes measured at base­
line (described above). 
In relation to the stated objectives, this design there­
fore examines whether and how any acute alterations in 
energy balance can culminate in chronic changes in 
energy balance (i.e. the acute effects of each treatment 
may be modified as participants become accustomed 
and adapt to it). To further inform such questions, dur­
ing the first and last week of the intervention partici­
pants will maintain detailed weighed records of their 
habitual food and fluid intakes for subsequent analysis 
of daily energy and macro-nutrient intakes using dietary 
analysis software (CompEat Pro). Additional data 
regarding feeding patterns will be gathered via analysis 
of time of day, daily frequency and energy content of 
individual eating occasions, with meals defined as inges­
tion of ≥1256 kJ at any given eating occasion and snacks 
defined as ingestion of <1256 kJ more than 45 minutes 
before or after a meal [77]. All participants will receive 
telephone reminders to ensure appropriate compliance 
to the dietary record process, as has been advocated and 
applied to good effect by others [24]. The food diaries 
provided to participants will also be accompanied by the 
same validated labelled magnitude scale [76] that parti­
cipants will have used during the first phase of testing 
to provide a rating of ‘pleasantness’ following the first 
and last mouthful of their lunchtime meal, thus inform­
ing research questions regarding psychological reward 
and food hedonics. Concurrent to these two periods of 
dietary recording, participants will also be fitted with a 
combined heart-rate/accelerometer (Actiheart, CamN­
tech) in order to accurately record energy expenditure/ 
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physical activity habits [54,55] for the entire duration of 
each 7 day assessment period (which will also be com­
plemented by daily records of participants physical in/ 
activities and sleep/waking times). Importantly, at the 
point when this physical activity monitor is fitted, parti­
cipants will be provided the following message both 
verbally and in writing to ensure that only genuinely 
meaningful behavioural responses are recorded: “Your 
lifestyle choices during this free-living monitoring period 
are central to this study. We are interested in any nat­
ural changes in your diet and/or physical activity habits, 
which you may or may  not make in  response to the  
intervention. This monitoring period has been carefully 
scheduled to avoid any pre-planned changes in these 
habits, such as a holiday or diet/exercise plan. You 
should inform us immediately if unforeseen factors 
external to the study may influence your lifestyle.” 
After each participant’s follow-up trial under Phase II, 
participants will continue adhering to their assigned 
intervention for at least 2 days to allow for the 48 hour 
dietary control (although up to 7 days will be permitted 
in participants for whom either the menstrual cycle 
need not be controlled for or when both trials can still 
occur within the follicular phase) before returning to 
the laboratory to repeat their breakfast trial exactly as 
described in relation to Objective i. This trial will there­
fore inform whether acute metabolic and/or behavioural 
effects may be modified following chronic exposure to 
each treatment. A formal exit interview will also be 
incorporated into this final visit during the afternoon 
post-prandial period to obtain qualitative data regarding 
participants’ experiences of the study and motives for 
any perceived changes in behaviour. 
Objective iii - In relation to this objective, relevant data 
will be gathered during the second phase of testing to 
explore how interactions between extended daily fasting 
may relate to insulin resistance and cardiovascular disease 
risk (whether related to or independent of changes in 
energy balance). From a whole-body perspective, highly 
relevant data will be gathered during the first and last week 
of the 6 week intervention using a subcutaneous continuous 
glucose monitor (iPro, Medtronic) to record 24 hour glu­
cose profiles for each participant (thus revealing whether 
either treatment alters either the average daily glucose con­
centration or the magnitude of hyperglycaemic excursions 
following meals). This real-world indication of glycaemic 
control will be complimented not only by simple compari­
son of changes in fasted glucose/insulin concentrations 
changes over the 6 weeks but also by way of an oral glucose 
tolerance test (OGTT) that will be conducted at baseline 
and follow-up in Phase II, immediately following each adi­
pose tissue sample. At a more reductionist level, the adipose 
tissue samples will be subjected to further analysis to deter­
mine the sensitivity of this particular tissue to insulin. 
Specifically, on the day that these samples are collected, adi­
pocytes will be isolated by collagenase digestion before 
determination of [U-14C]-D-glucose uptake at basal, sub-
maximal (50 pmol•l-1) and maximal (20 nmol•l-1) insulin 
concentrations. This glucose uptake assay has been shown 
to accurately reflect 3-O-methylglucose transport under the 
conditions described [78,79] and the resultant data will be 
expressed both as pmol•min-1 relative both to lipid mass 
[80] and, following analysis of cell size, to cell surface area. 
This will be in addition to subsequent analyses for the total 
protein content of GLUT4 and Akt in this tissue and the 
expression of key genes implicated in lipolysis (e.g. HSL and 
ATGL), lipogenesis (e.g. PPARg, PGC1a, SREBP1c)  and  
more generally in glucose uptake and oxidation (e.g. 
GLUT4, PDK4, AMPKa-1/2, resistin,  RBP4, leptin and  adi­
ponectin) and/or insulin signalling (e.g. IRS1/2, PI3K, Akt 
and TBC1 domain family member 4), thus informing 
whether there is any adaptive response to the intervention 
at the level of adipose tissue gene expression and protein 
content. 
Finally, in relation to cardiovascular disease risk, mea­
surements of blood lipid profiles, cytokine responses, 
CRP and blood pressure (DINAMAP Pro 100-400 V2, 
UK) will be contrasted between participants’ baseline 
and final follow-up trials, as will the expression of other 
relevant genes in adipose tissue samples (e.g. interleu­
kin-6 and TNF-a). All hormones/cytokines to be mea­
sured in the proposed work will be quantified via 
ELISA, with whole blood glucose determined using a 
YSI analyser, plasma glucose, NEFA, cholesterol and 
urea measured using a spectrophotometer and gene 
expression using TaqMan® Real-Time PCR. 
Discussion 
Despite clear support for a positive relationship between 
extended daily fasting, energy balance and a range of 
inter-related negative health consequences, there 
remains a distinct lack of evidence regarding any direct 
causal relationships or mechanisms of action. The novel 
data generated by this study will be critical both to the 
progression of scientific understanding and to the appli­
cation of these findings within a public health setting. In 
particular, very simple and easily adopted public health 
messages could be communicated based on the findings 
of this study, not only in terms of whether breakfast 
consumption/omission represents an effective strategy 
for weight loss or improved health in different popula­
tions but also the mechanisms identified can be facili­
tated to maximise such benefits. 
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